1: Anghel N, Imhof D, Winzer P, Balmer V, Ramseier J, Haenggeli K, Choi R,
Hulverson MA, Whitman GR, Arnold SLM, Ojo KK, Van Voorhis WC, Doggett JS,
Ortega-Mora LM, Hemphill A. Endochin-like quinolones (ELQs) and bumped kinase
inhibitors (BKIs): Synergistic and additive effects of combined treatments
against Neospora caninum infection in vitro and in vivo. Int J Parasitol Drugs
Drug Resist. 2021 Dec;17:92-106. doi: 10.1016/j.ijpddr.2021.08.007. Epub 2021
Aug 28. PMID: 34482255; PMCID: PMC8416643.
2: Lawres LA, Garg A, Kumar V, Bruzual I, Forquer IP, Renard I, Virji AZ,
Boulard P, Rodriguez EX, Allen AJ, Pou S, Wegmann KW, Winter RW, Nilsen A, Mao
J, Preston DA, Belperron AA, Bockenstedt LK, Hinrichs DJ, Riscoe MK, Doggett JS,
Ben Mamoun C. Radical cure of experimental babesiosis in immunodeficient mice
using a combination of an endochin-like quinolone and atovaquone. J Exp Med.
2016 Jun 27;213(7):1307-18. doi: 10.1084/jem.20151519. Epub 2016 Jun 6. PMID:
27270894; PMCID: PMC4925016.
3: Martynowicz J, Doggett JS, Sullivan WJ Jr. Efficacy of Guanabenz Combination
Therapy against Chronic Toxoplasmosis across Multiple Mouse Strains. Antimicrob
Agents Chemother. 2020 Aug 20;64(9):e00539-20. doi: 10.1128/AAC.00539-20. PMID:
32540979; PMCID: PMC7449173.
4: Anghel N, Balmer V, Müller J, Winzer P, Aguado-Martinez A, Roozbehani M, Pou
S, Nilsen A, Riscoe M, Doggett JS, Hemphill A. Endochin-Like Quinolones Exhibit
Promising Efficacy Against Neospora Caninum in vitro and in
Experimentally Infected Pregnant Mice. Front Vet Sci. 2018 Nov 19;5:285. doi:
10.3389/fvets.2018.00285. PMID: 30510935; PMCID: PMC6252379.